Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| SHPG | Shire PLC Sponsored ADR | 0.06% | 176.41 | 0.4% | $129.75m | |
| PRGO | Perrigo Co. Plc | -1.53% | 72.56 | 6.8% | $98.05m | |
| MNK | Mallinckrodt Plc | -2.62% | 29.70 | 21.1% | $71.66m | |
| JAZZ | Jazz Pharmaceuticals Plc | -1.14% | 159.17 | 2.2% | $69.03m | |
| ENDP | Endo International Plc | -0.25% | 15.85 | 8.9% | $59.65m | |
| PTLA | Portola Pharmaceuticals, Inc. | -3.30% | 28.40 | 7.7% | $40.55m | |
| UTHR | United Therapeutics Corporation | 1.63% | 125.94 | 14.4% | $39.16m | |
| SAGE | SAGE Therapeutics, Inc. | 0.26% | 145.51 | 9.6% | $36.92m | |
| CTLT | Catalent Inc | 0.96% | 43.00 | 2.4% | $36.86m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -1.24% | 117.30 | 18.7% | $30.73m | |
| ZGNX | Zogenix, Inc. | -0.62% | 48.50 | 11.9% | $29.86m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | -0.17% | 140.94 | 6.8% | $29.26m | |
| SUPN | Supernus Pharmaceuticals, Inc. | -4.27% | 46.00 | 6.2% | $27.18m | |
| MDCO | Medicines Company | -1.47% | 33.56 | 21.8% | $25.01m | |
| ICLR | ICON Plc | -1.65% | 145.27 | 4.2% | $23.83m |
Company Profile
Zogenix, Inc. is a pharmaceutical compan. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen J. Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.